Toll-like receptor expression and activation in astroglia: Differential regulation by HIV-1 Tat, gp120, and morphine

Immunological Investigations

Volumn 40, Issue 5, 2011, Pages 498-522

  El Hage, Nazira ^a   Podhaizer, Elizabeth M ^a   Sturgill, Jamie ^a   Hauser, Kurt F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Cytokines; Free radicals; Glia; HIV 1 proteins; Innate immunity; Neuroplasticity; Opioid abuse

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 120; MORPHINE; NARCOTIC AGENT; NITRITE; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR; TRANSACTIVATOR PROTEIN;

ANIMAL; ARTICLE; ASTROCYTE; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOUSE; PROTEIN TRANSPORT; SECRETION;

ANIMALS; ASTROCYTES; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; HIV ENVELOPE PROTEIN GP120; HUMANS; IMMUNITY, INNATE; MICE; MICE, INBRED ICR; MORPHINE; NARCOTICS; NITRITES; PROTEIN TRANSPORT; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TOLL-LIKE RECEPTORS;

EID: 80053307621     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2011.561904     Document Type: Article

References (89)

1. Akira, S., Kishimoto, T. (1992). IL-6 and NF-IL-6 in acute phase response and viral infection. Immunol. Rev. 313:47-50.
2. Akira, S., Hoshino, K., Kaisho, T. (2000). The role of Toll-like receptors and MyD88 in innate immune responses. J. Endotoxin Res. 6:383-387. (Pubitemid 32241948)
3. Akira, S., Yamamoto, M., Takeda, K. (2003). Role of adapters in Toll-like receptor signalling. Biochem. Soc. Trans. 31:637-642. (Pubitemid 36750746)
4. Ashkar, A. A., Bauer, S., Mitchell, W. J., Vieira, J., Rosenthal, K. L. (2003). Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J Virol 77:8948-8956. (Pubitemid 36936104)
5. Ashkar, A. A., Yao, X. D., Gill, N., Sajic, D., Patrick, A. J., Rosenthal, K. L. (2004). Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J. Infect. Dis. 190:1841-1849. (Pubitemid 39487831)
6. Bachis, A., Cruz, M. I., Mocchetti, I. (2010). M-tropic HIV envelope protein gp120 exhibits a different neuropathological profile than T-tropic gp120 in rat striatum. Eur. J. Neurosci. 32:570-578.
7. Bafica, A., Scanga, C. A., Schito, M., Chaussabel, D., Sher, A. (2004). Influence of coinfecting pathogens on HIV expression: Evidence for a role of Toll-like receptors. J. Immunol. 172:7229-7234. (Pubitemid 38747580)
8. Bal-Price, A., Brown, G. C. (2001). Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci. 21:6480-6491. (Pubitemid 32781092)
9. Becher, B., Prat, A., Antel, J. P. (2000). Brain-immune connection: Immuno-regulatory properties of CNS-resident cells. Glia 29:293-304. (Pubitemid 30121420)
10. Bell, J. E., Brettle, R. P., Chiswick, A., Simmonds, P. (1998). HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 121:2043-2052. (Pubitemid 28497903)
11. Bochud, P. Y., Hersberger, M., Taffe, P., Bochud, M., Stein, C. M., Rodrigues, S. D., Calandra, T., Francioli, P., Telenti, A., Speck, R. F., Aderem, A. (2007). Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS 21:441-446.
12. Bonnet, M. P., Beloeil, H., Benhamou, D., Mazoit, J. X., Asehnoune, K. (2008). The mu opioid receptor mediates morphine-induced tumor necrosis factor and interleukin-6 inhibition in toll-like receptor 2-stimulated monocytes. Anesth. Analg. 106:1142-1149. (Pubitemid 351450539)
13. Borysiewicz, E., Fil, D., Konat, G. W. (2009). Rho proteins are negative regulators of TLR2, TLR3, and TLR4 signaling in astrocytes. J. Neurosci. Res. 87:1565-1572.
14. Bowman CC, Rasley A, Tranguch SL, Marriott I (2003) Cultured astrocytes express toll-like receptors for bacterial products. Glia 43:281-291. (Pubitemid 37047684)
15. Brosnan, C. F., Battistini, L., Raine, C. S., Dickson, D. W., Casadevall, A., Lee, S. C. (1994). Reactive nitrogen intermediates in human neuropathology: An overview. Dev. Neurosci. 16:152-161.
16. Bsibsi, M., Ravid, R., Gveric, D., Van Noort, J. M. (2002) Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61:1013-1021. (Pubitemid 35278723)
17. Bsibsi, M., Persoon-Deen, C., Verwer, R. W., Meeuwsen, S., Ravid, R., Van Noort, J. M. (2006). Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 53:688-695.
18. Carpentier, P. A., Begolka, W. S., Olson, J. K., Elhofy, A., Karpus, W. J., Miller, S. D. (2005). Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 49:360-374. (Pubitemid 40222914)
19. Carpentier, P. A., Williams, B. R., Miller, S. D. (2007). Distinct roles of protein kinase R and toll-like receptor 3 in the activation of astrocytes by viral stimuli. Glia 55:239-252. (Pubitemid 46225956)
20. Carpentier, P. A., Duncan, D. S., Miller, S. D. (2008). Glial toll-like receptor signaling in central nervous system infection and autoimmunity. Brain Behav. Immun. 22:140-147. (Pubitemid 350299811)
21. Chao, C. C., Hu, S., Molitor, T. W., Shaskan, E. G., Peterson, P. K. (1992). Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149:2736-2741.
22. De Miranda, J., Yaddanapudi, K., Hornig, M., Lipkin, W. I. (2009). Astrocytes recognize intracellular polyinosinic-polycytidylic acid via MDA-5. FASEB J. 23:1064-1071.
23. Dong, Y., Benveniste, E. N. (2001). Immune function of astrocytes. Glia 36:180-190. (Pubitemid 33055906)
24. Doyle, S., Vaidya, S., O'Connell, R., Dadgostar, H., Dempsey, P., Wu, T., Rao, G., Sun, R., Haberland, M., Modlin, R., Cheng, G. (2002). IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17:251-263. (Pubitemid 35279547)
25. 2+, and the release of MCP-1, RANTES and IL-6 by astrocytes treated with opiates and HIV-1 Tat. Glia 50:91-106. (Pubitemid 40695264)
26. El-Hage, N., Wu, G., Wang, J., Ambati, J., Knapp, P. E., Bruce-Keller, A., Hauser, K. F. (2006a). HIV Tat1-72aa and Opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia 53:132-146.
27. El-Hage, N., Wu, G., Ambati, J., Bruce-Keller, A., Knapp, P. E., Hauser, K. F. (2006b). CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates. J. Neuroimmunol. 178:9-16. (Pubitemid 44307341)
28. El-Hage, N., Bruce-Keller, A. J., Knapp, P. E., Hauser, K. F. (2008a). CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice. J. Neuroimmun. Pharmacol. 3:275-285.
29. i, NF-kappaB trafficking and transcription. PLoS One 3:e4093.
30. Equils, O., Faure, E., Thomas, L., Bulut, Y., Trushin, S., Arditi, M. (2001). Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4. J. Immunol. 166:2342-2347. (Pubitemid 32173467)
31. Equils, O., Schito, M. L., Karahashi, H., Madak, Z., Yarali, A., Michelsen, K. S., Sher, A., Arditi, M. (2003). Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: Implications of simultaneous activation of TLRs on HIV replication. J. Immunol. 170:5159-5164. (Pubitemid 36554748)
32. Farina, C., Krumbholz, M., Giese, T., Hartmann, G., Aloisi, F., Meinl, E. (2005). Preferential expression and function of Toll-like receptor 3 in human astrocytes. J. Neuroimmunol. 159:12-19. (Pubitemid 40126172)
33. Farina, C., Aloisi, F., Meinl, E. (2007). Astrocytes are active players in cerebral innate immunity. Trends Immunol. 28:138-145. (Pubitemid 46283692)
34. Fitting, S., Zou, S., Chen, W., Vo, P., Hauser, K. F., Knapp, P. E. (2010). Regional Heterogeneity and diversity in cytokine and chemokine production by astroglia: Differential responses to HIV-1 Tat, gp120 and morphine revealed by multiplex analysis. J. Proteome Res. 9:1795-1804.
35. Fuller, S., Steele, M., Munch, G. (2009). Activated astroglia during chronic inflammation in Alzheimer's disease-Do they neglect their neurosupportive roles? Mutat. Res. Sep. 11 [Epub ahead of print].
36. Gendelman, H. E., Persidsky, Y., Ghorpade, A., Limoges, J., Stins, M., Fiala, M., Morrisett, R. (1997). The neuropathogenesis of the AIDS dementia complex. AIDS 11 Suppl A: S35-S45.
37. Gill, N., Deacon, P. M., Lichty, B., Mossman, K. L., Ashkar, A. A. (2006). Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production. J. Virol. 80:9943-9950. (Pubitemid 44522588)
38. Griess, P. (1879). Bemernkugen zu der Abhandlung der HH: Wesely und Benedikt "Ueber einige Azoverbindungen". Ber. Dtsch. Chem. Ges. 12:426-428.
39. Hauser, K. F., El-Hage, N., Stiene-Martin, A., Maragos, W. F., Nath, A., Persidsky, Y., Volsky, D. J., Knapp, P. E. (2007). HIV-1 neuropathogenesis: Glial mechanisms revealed through substance abuse. J. Neurochem. 100:567-586. (Pubitemid 46095610)
40. Heggelund, L., Muller, F., Lien, E., Yndestad, A., Ueland, T., Kristiansen, K. I., Espevik, T., Aukrust, P., Froland, S. S. (2004a). Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication. Clin. Infect. Dis. 39:264-269. (Pubitemid 38971499)
41. Heggelund, L., Flo, T., Berg, K., Lien, E., Mollnes, T. E., Ueland, T., Aukrust, P., Espevik, T., Froland, S. S. (2004b). Soluble toll-like receptor 2 in HIV infection: association with disease progression. AIDS 18:2437-2439. (Pubitemid 40065915)
42. Hutchinson, M. R., Bland, S. T., Johnson, K. W., Rice, K. C., Maier, S. F., Watkins, L. R. (2007). Opioid-induced glial activation: Mechanisms of activation and implications for opioid analgesia, dependence, and reward. Sci. World J. 7:98-111. (Pubitemid 350292608)
43. Hutchinson, M. R., Zang, Y., Brown, K., Coats, B. D., Shridhar, M., Sholar, P. W., Patel, S. J., Crysdale, N. Y., Harrison, J. A., Maier, S. F., Rice, K. C., Watkins, L. R. (2008). Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur. J. Neurosci. 28:20-29.
44. Iwasaki, A., Medzhitov, R. (2010). Regulation of adaptive immunity by the innate immune system. Science 327:291-295.
45. Jack, C. S., Arbour, N., Manusow, J., Montgrain, V., Blain, M., McCrea, E., Shapiro, A., Antel, J. P. (2005). TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 175:4320-4330. (Pubitemid 41361966)
46. Kariko, K., Weissman, D., Welsh, F. A. (2004). Inhibition of toll-like receptor and cytokine signaling-A unifying theme in ischemic tolerance. J. Cereb. Blood Flow Metab. 24:1288-1304. (Pubitemid 39482492)
47. Kaul, M., Garden, G. A., Lipton, S. A. (2001). Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988-994. (Pubitemid 32335850)
48. Kaul, M., Ma, Q., Medders, K. E., Desai, M. K., Lipton, S. A. (2007). HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ. 14:296-305. (Pubitemid 46092232)
49. Laflamme, N., Rivest, S. (2001). Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J. 15:155-163. (Pubitemid 32061666)
50. Lafon, M., Megret, F., Lafage, M., Prehaud, C. (2006). The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA. Mol. Neurosci. 29:185-94. (Pubitemid 44684494)
51. Lander, H. M., Ogiste, J. S., Pearce, S. F., Levi, R., Novogrodsky, A. (1995). Nitric oxidestimulated guanine nucleotide exchange on p21ras. J. Biol. Chem. 270:7017-7020.
52. Li, Y., Sun, X., Zhang, Y., Huang, J., Hanley, G., Ferslew, K. E., Peng, Y., Yin, D. (2009). Morphine promotes apoptosis via TLR2, and this is negatively regulated by betaarrestin 2. Biochem. Biophys. Res. Commun. 378:857-861.
53. Liu, H. C., Anday, J. K., House, S. D., Chang, S. L. (2004). Dual effects of morphine on permeability and apoptosis of vascular endothelial cells: Morphine potentiates lipopolysaccharide-induced permeability and apoptosis of vascular endothelial cells. J. Neuroimmunol. 146:13-21. (Pubitemid 38032951)
54. Liu, X., Mosoian, A., Li-Yun, C. T., Zerhouni-Layachi, B., Snyder, A., Jarvis, G. A., Klotman, M. E. (2006). Gonococcal lipooligosaccharide suppresses HIV infection in human primary macrophages through induction of innate immunity. J. Infect. Dis. 194:751-759. (Pubitemid 44344121)
55. MacDonald, E. M., Savoy, A., Gillgrass, A., Fernandez, S., Smieja, M., Rosenthal, K. L., Ashkar, A. A., Kaushic, C. (2007). Susceptibility of human female primary genital epithelial cells to herpes simplex virus, type-2 and the effect of TLR3 ligand and sex hormones on infection. Biol. Reprod. 77:1049-1059. (Pubitemid 350197982)
56. Martinelli, E., Cicala, C., Van, R. D., Goode, D. J., Macleod, K., Arthos, J., Fauci, A. S. (2007). HIV-1 gp120 inhibits TLR9-mediated activation and IFN-α secretion in plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. USA 104:3396-3401. (Pubitemid 46364170)
57. Martinson, J. A., Tenorio, A. R., Montoya, C. J., Al-Harthi, L., Gichinga, C. N., Krieg, A. M., Baum, L. L., Landay, A. L. (2007). Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals. Immunol. 120:526-535. (Pubitemid 46365012)
58. Matsuzawa, A., Saegusa, K., Noguchi, T., Sadamitsu, C., Nishitoh, H., Nagai, S., Koyasu, S., Matsumoto, K., Takeda, K., Ichijo, H. (2005). ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat. Immunol. 6:587-592. (Pubitemid 41710729)
59. McGeer, P. L., McGeer, E. G. (2004). Inflammation and the degenerative diseases of aging. Ann. NY Acad. Sci. 1035:104-116. (Pubitemid 40362329)
60. McKimmie, C. S., Fazakerley, J. K. (2005). In response to pathogens, glial cells dynamically and differentially regulate Toll-like receptor gene expression. J. Neuroimmunol. 169:116-125. (Pubitemid 41527097)
61. Medders, K. E., Sejbuk, N. E., Maung, R., Desai, M. K., Kaul, M. (2010). Activation of p38 MAPK is required in monocytic and neuronal cells for HIV glycoprotein 120-induced neurotoxicity. J. Immunol. 185:4883-4895.
62. Medzhitov, R., Janeway, C. A. (1999). Innate immune induction of the adaptive immune response. Cold Spring Harb. Symp. Quant. Biol. 64:429-435. (Pubitemid 30329308)
63. Mishra, B. B., Mishra, P. K., Teale, J. M. (2006). Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis. J. Neuroimmunol. 181:46-56. (Pubitemid 44827289)
64. Mustafa, A. K., Gadalla, M. M., Snyder, S. H. (2009). Signaling by gasotransmitters. Sci. Signal 2: re2.
65. Nath, A., Hauser, K. F., Wojna, V., Booze, R. M., Maragos, W., Prendergast, M., Cass, W., Turchan, J. T. (2002). Molecular basis for interactions of HIV and drugs of abuse. J. Acquir. Immune Defic. Syndr. 31 Suppl 2:S62-S69. (Pubitemid 35190560)
66. O'Hara, S. P., Small, A. J., Gajdos, G. B., Badley, A. D., Chen, X. M., Larusso, N. F. (2009). HIV-1 Tat protein suppresses cholangiocyte toll-like receptor 4 expression and defense against Cryptosporidium parvum. J. Infect. Dis. 199:1195-1204.
67. Park, C., Lee, S., Cho, I.-H., Lee, H.-K., Kim, D., Choi, S.-Y., Oh, S.-B., Park, K., Kim, J.-S., Lee, S.-J. (2006). TLR 3-mediated signal induces proinflammatory cytokine and chemokine gene expression in astrocytes: differential signaling mechanisms of TLR3-induced IP-10 and IL-8 gene expression. Glia 53:248-256. (Pubitemid 43221347)
68. Phulwani, N. K., Esen, N., Syed, M. M., Kielian, T. (2008). TLR2 expression in astrocytes is induced by TNF-alpha- and NF-kappa B-dependent pathways. J. Immunol. 181:3841-3849.
69. Rao, K. M. (2001). MAP kinase activation in macrophages. J Leukoc Biol 69:3-10. (Pubitemid 32095111)
70. Rivieccio, M. A., Suh, H. S., Zhao, Y., Zhao, M. L., Chin, K. C., Lee, S. C., Brosnan, C. F. (2006). TLR3 ligation activates an antiviral response in human fetal astrocytes: A role for viperin/cig5. J. Immunol. 177:4735-4741. (Pubitemid 44469807)
71. Ryan, K. A., Smith, M. F., Jr., Sanders, M. K., Ernst, P. B. (2004). Reactive oxygen and nitrogen species differentially regulate Toll-like receptor 4-mediated activation of NF-kappa B and interleukin-8 expression. Infect. Immun. 72:2123-2130. (Pubitemid 38419925)
72. Salaria, S., Badkoobehi, H., Rockenstein, E., Crews, L., Chana, G., Masliah, E., Everall, I. P., and the HNRC Group (2007) Toll-like receptor pathway gene expression is associated with human immunodeficiency virus-associated neurodegeneration. J. NeuroVirol. 13:496-503.
73. Sanghavi, S. K., Reinhart, T. A. (2005). Increased expression of TLR3 in lymph nodes during simian immunodeficiency virus infection: Implications for inflammation and immunodeficiency. J. Immunol. 175:5314-5323. (Pubitemid 41456417)
74. Scheller, C., Ullrich, A., McPherson, K., Hefele, B., Knoferle, J., Lamla, S., Olbrich, A. R., Stocker, H., Arasteh, K. Ter M. V., Rethwilm, A., Koutsilieri, E., Dittmer, U. (2004). CpG oligodeoxynucleotides activate HIV replication in latently infected human T cells. J. Biol. Chem. 279:21897-21902. (Pubitemid 38679379)
75. Schlaepfer, E., Audige, A., Von, B. B., Manolova, V., Weber, M., Joller, H., Bachmann, M. F., Kundig, T. M., Speck, R. F. (2004). CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo. J. Virol. 78:12344-12354. (Pubitemid 39458753)
76. Schlaepfer, E., Audige, A., Joller, H., Speck, R. F. (2006). TLR7/8 triggering exerts opposing effects in acute versus latent HIV infection. J. Immunol. 176:2888-2895.
77. Scumpia, P. O., Kelly, K. M., Reeves, W. H., Stevens, B. R. (2005). Double-stranded RNA signals antiviral and inflammatory programs and dysfunctional glutamate transport in TLR3-expressing astrocytes. Glia 52:153-162. (Pubitemid 41652919)
78. Sheng, W. S., Hu, S., Gekker, G., Zhu, S., Peterson, P. K., Chao, C. C. (1997). Immunomodulatory role of opioids in the central nervous system. Arch. Immunol. Ther. Exp. (Warsz) 45:359-366. (Pubitemid 28098862)
79. Stiene-Martin, A., Zhou, R., Hauser, K. F. (1998). Regional, developmental, and cell cycle-dependent differences in μ, δ and k-opioid receptor expression among cultured mouse astrocytes. Glia 22:249-259. (Pubitemid 28159016)
80. Suh, H. S., Brosnan, C. F., Lee, S. C. (2009). Toll-like receptors in CNS viral infections. Curr. Top. Microbiol. Immunol. 336:63-81.
81. Sundstrom, J. B., Little, D. M., Villinger, F., Ellis, J. E., Ansari, A. A. (2004). Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells. J. Immunol. 172:4391-4401. (Pubitemid 38375254)
82. Suzuki, Y. J., Forman, H. J., Sevanian, A. (1997). Oxidants as stimulators of signal transduction. Free Radic. Biol. Med. 22:269-285. (Pubitemid 26399334)
83. Takeda, K., Kaisho, T., Akira, S (2003). Toll-like receptors. Annu. Rev. Immunol. 21:335-376. (Pubitemid 37174535)
84. Tsan, M. F., Gao, B. (2004). Endogenous ligands of Toll-like receptors. J. Leukoc. Biol. 76:514-519. (Pubitemid 39129081)
85. Wang, J., Barke, R. A., Charboneau, R., Schwendener, R., Roy, S. (2008). Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NF-kappa B signaling. J. Immunol. 180:3594-3600.
86. Watkins, L. R., Hutchinson, M. R., Rice, K. C., Maier, S. F. (2009). The "toll" of opioidinduced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol. Sci. 30(11):581-591.
87. Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., Akira, S. (2003). Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301:640-643. (Pubitemid 36927946)
88. Zekki, H., Feinstein, D. L., Rivest, S. (2002). The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS. Brain Pathol. 12:308-319. (Pubitemid 34743213)
89. Ziegler, G., Harhausen, D., Schepers, C., Hoffmann, O., Rohr, C., Prinz, V., Konig, J., Lehrach, H., Nietfeld, W., Trendelenburg, G. (2007). TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem. Biophys. Res. Commun. 359:574-579. (Pubitemid 46898990)